Clinical Trials on Growth Hormone

Total 35265 results

GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology

Completed

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (Phase 1)

Growth Hormone Deficiency
University of Aarhus

Completed

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

Growth Hormone Deficiency

Denmark
Ferring Pharmaceuticals
Ferring SAU

Completed

Adipocyte Function and Somtropin Deficiency (FAYDS)

Growth Hormone Deficiency

Spain
Sanofi

Completed

Practicability and Acceptability of Stylomax® in Children

Growth Hormone Deficiency

France
Children's Mercy Hospital Kansas City
Genentech, Inc.

Completed

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Growth Hormone Deficiency

United States
Novo Nordisk A/S

Completed

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

Healthy | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency

Germany
Ascendis Pharma Endocrinology Division A/S

Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA (SkybriGHt)

Growth Hormone Deficiency

United States
Columbia University

Not yet recruiting

The AgRP and GH/IGF-1 Axis in Children

Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study of TV-1106 in Growth Hormone-Deficient Adults

Growth Hormone Deficiency

United States, Austria, Czechia, Greece, Hungary, Italy, Russian Federation
University of Salerno

Unknown

Gene Expression in Monocytes of Growth Hormone Deficient Children (GEMGH)

Growth Hormone Deficiency

Italy
Vedic Lifesciences Pvt. Ltd.

Completed

Assessment of the Acute Effect of IP

Deficiency Growth Hormone

India
Aileron Therapeutics, Inc.

Completed

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Growth Hormone Deficiency

United States
HanAll BioPharma Co., Ltd.

Completed

Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers (HL-032)

Growth Hormone Deficiency

Korea, Republic of
LG Life Sciences

Completed

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Growth Hormone Deficiency
Pfizer

Completed

Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects (CHOOSE)

Growth Hormone Deficiency

United Kingdom, Czech Republic, Germany, Netherlands, Slovakia, Sweden, Turkey
Children's Mercy Hospital Kansas City

Completed

Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing

Growth Hormone Deficiency

United States
Eli Lilly and Company
University of Pisa; University of Padova; University of Milan; University of Naples

Completed

Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

Growth Hormone Deficiency

United States
Pfizer

Completed

Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents (TAUBER)

Growth Hormone Deficiency
Vanderbilt University
Pfizer; National Center for Research Resources (NCRR)

Terminated

Growth Hormone's Effect on the Cardiovascular System

Growth Hormone Deficiency

United States
University Hospital, Angers
Novo Nordisk A/S

Unknown

Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

Growth Hormone Deficiency

France
Pennington Biomedical Research Center

Completed

Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine

Aging | Growth Hormone Treatment
Novo Nordisk A/S

Completed

Effect of Growth Hormone in Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children | Growth Disorder | Idiopathic Short Stature

United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency (ELEVATE)

GHD

United States
Columbia University

Recruiting

Effects of GH and Lirglutide on AgRP

Healthy | Growth Hormone Deficiency

United States
University of Mary Hardin-Baylor

Completed

The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone

Blood Flow Restriction | Growth Hormone | Arginine | Strength Outcomes

United States
Pfizer

Terminated

Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy (SGA-POWER)

Infant, Small for Gestational Age | Growth Hormone Therapy

Germany
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency (ESCALATE)

GHD
EMD Serono

Completed

ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency

Healthy
Garcia, Jose M., MD, PhD

Completed

Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD

Adult-Onset Growth Hormone Deficiency

United States
Novo Nordisk A/S

Completed

Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)

Growth Hormone Deficiency in Children | Growth Disorder

United States, United Kingdom
The University of Texas Medical Branch, Galveston
Pfizer; United States Department of Defense

Completed

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

Burns | Growth Hormone Treatment

United States
Medical University of Vienna

Completed

Ghrelin, Growth Hormone and Growth Factors at High Altitude

Healthy | Growth Hormone
Novo Nordisk A/S

Completed

A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects

Healthy Volunteers | Growth Hormone Deficiency

Germany
Ipsen

Completed

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders (iNCGS)

Growth Hormone Disorders

United Kingdom
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity

Obesity | Growth Hormone

United States
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Denmark, Sweden
Novo Nordisk A/S

Completed

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Novo Nordisk A/S

Completed

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Novo Nordisk A/S

Completed

Growth Hormone Deficiency in Adults (GHDA)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Novo Nordisk A/S

Completed

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency (REAL 2)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Denmark, France, Germany, Japan, Sweden, United Kingdom
Novo Nordisk A/S

Completed

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

United States
Novo Nordisk A/S

Completed

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Sweden, Austria, Spain, Switzerland, Germany, France, Australia, Poland, United Kingdom, Norway, Belgium, Hungary
Novo Nordisk A/S

Completed

Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

United States
Novo Nordisk A/S

Completed

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency

Germany
Novo Nordisk A/S

Recruiting

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

United States, Japan, Israel, India, Austria, Slovenia, Belgium, Brazil, France, Germany, Sweden, Turkey, Ukraine
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

France, Israel, Austria, Spain, Switzerland, North Macedonia, Norway, Slovenia, Belgium, Sweden
Novo Nordisk A/S

Completed

Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. (REAL 1)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

United States, Poland, India, Japan, Russian Federation, United Kingdom, Germany, Sweden, Israel, Malaysia, Turkey, South Africa, Australia, Latvia, Lithuania, Romania, Brazil, Norway, Ukraine
Novo Nordisk A/S

Completed

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Growth Hormone Disorder | Adult Growth Hormone Deficiency

France
University of Palermo

Completed

Adrenal Function in GHD Children

Growth Hormone Treatment | Adrenal; Functional Disturbance

Italy
Eli Lilly and Company

Completed

A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults (HypoCCS)

Hypopituitarism | Pituitary Insufficiency | Growth Hormone Deficiency, Adult

Clinical Trials on Growth Hormone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations